---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

WuXi AppTec

🌎 wuxiapptec.com

WuXi AppTec is a global company headquartered in Shanghai, providing a comprehensive range of R&D and manufacturing services to the pharmaceutical and biotech industries. With operations across Asia, Europe, and North America, the company supports over 6,000 customers in advancing healthcare products through integrated services that include drug discovery, clinical research, and advanced therapies. WuXi AppTec aims to enable every drug to be made and every disease to be treated, receiving recognition for its commitment to sustainability and innovation.

---

WuXi AppTec - Latest News and Updates

• WuXi AppTec is involved in the research and development of a prodrug for hepatitis B virus capsid assembly modulation.
• Christopher Andino has left WuXi AppTec, where he served as a Senior Laboratory Technician in the United States, to join Merck as a Deviation Management Specialist.
• Dr. Debra Yu previously served as Vice President of Strategy at WuXi AppTec.
• Dongdi Sun, Director of Chemistry Laboratory at WuXi AppTec (Suzhou) Co., Ltd, and Xiaolong Rong, Technical Director of Chemistry Laboratory at WuXi AppTec, are listed as speakers for the 2024 E&L Asia conference.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.